Effects of Marine Actinomycin X2 on VCAM-1 Expression in CVB3-infected ECV304 Cells

DAI Guokui,WU Sha,SHI Shanshan,SUN Yifan,JIANG Zhenyou,ZHOU lin
DOI: https://doi.org/10.13431/j.cnki.immunol.j.20120137
2012-01-01
Abstract:To investigate antivirus affects of marine actinomycin X2 against Coxsackieviru(CVB3),we detected the expression and secretion of vascular cell adhesion molecule(VCAM-1) in CVB3-infected ECV304 cells,and studied the effects of marine actinomycin X2 on the expression of VCAM-1 in CVB3-infected ECV304 cells.By adopting MTT methods,we detected the inhibitory action of virus by using different concentrations of marine actinomycin X2 and study the efficacy of viral adsorption.Cytoplasmic RNA from ECV304 cells was extracted by the Trizol method and mRNA levels of VCAM-1 were assayed by reverse transcript-polymerase chain reaction(RT-PCR).Flow cytometer was used to detect ICAM-1 expression on the infected ECV304 in different time courses respectively.We found that marine actinomycin X2 could inhibit virus before absorption of CVB3 into the normal cells and the SI was 63.88.The normal ECV304 did not express VCAM-1 mRNA in all 54 hours,but in the infected ECV304 cells,the expression of VCAM-1 mRNA was increased in 6-54 hours among which the VCAM-1 mRNA reached a peak at 12 hours point post-infection.The infection of CVB3 increased VCAM-1 protein expression on the surface of ECV304 at 12-48 hours.In CVB3+X2 group,the expression of VCAM-1 mRNA was lower than that of CVB3 group at 12-54 hours(P0.05),and the expression of VCAM-1 protein was lower than that of CVB3 group(P0.05) at 12-24 hours.In conclusion,marine actinomycin X2 has anti-viral function,and has protective effects on the injured ECV304 exposed to CVB3.
What problem does this paper attempt to address?